Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Birkholz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|March 30, 2007
Strategies for immune intervention; from bench to bedside: Symposium 2006 of the Collaborative Research Center "Strategies of cellular immune intervention" July 17th-18th, Erlangen, GermanyJan Dörrie, Katrin Birkholz, Niels Schaft
Cancer Immunology, Immunotherapy : CII|February 1, 2008
Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, GermanyNiels Schaft, Katrin Birkholz, Christian Hofmann, et al.
Breast Cancer Research and Treatment|February 13, 2014
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II studyPeyman Hadji, Annette Kauka, May Ziller, et al.
Journal of Immunological Methods|May 12, 2009
A fast and robust method to clone and functionally validate T-cell receptorsKatrin Birkholz, Christian Hofmann, Stefanie Hoyer, et al.
Blood|June 23, 2010
Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentationKatrin Birkholz, Michael Schwenkert, Christian Kellner, et al.
Journal of Bone Oncology|February 25, 2016
The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancerPeyman Hadji, May Ziller, Tobias Maurer, et al.
Cancer Immunology, Immunotherapy : CII|October 31, 2015
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backboneChristian Krug, Katrin Birkholz, Alexander Paulus, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
The Canadian Journal of Urology|June 19, 2012
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastasesUlf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, et al.
The World Allergy Organization Journal|April 3, 2019
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen seasonRalph Mösges, Nils Y Breitrück, Silke Allekotte, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|March 30, 2007
Strategies for immune intervention; from bench to bedside: Symposium 2006 of the Collaborative Research Center "Strategies of cellular immune intervention" July 17th-18th, Erlangen, GermanyJan Dörrie, Katrin Birkholz, Niels Schaft
Cancer Immunology, Immunotherapy : CII|February 1, 2008
Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, GermanyNiels Schaft, Katrin Birkholz, Christian Hofmann, et al.
Breast Cancer Research and Treatment|February 13, 2014
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II studyPeyman Hadji, Annette Kauka, May Ziller, et al.
Journal of Immunological Methods|May 12, 2009
A fast and robust method to clone and functionally validate T-cell receptorsKatrin Birkholz, Christian Hofmann, Stefanie Hoyer, et al.
Blood|June 23, 2010
Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentationKatrin Birkholz, Michael Schwenkert, Christian Kellner, et al.
Journal of Bone Oncology|February 25, 2016
The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancerPeyman Hadji, May Ziller, Tobias Maurer, et al.
Cancer Immunology, Immunotherapy : CII|October 31, 2015
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backboneChristian Krug, Katrin Birkholz, Alexander Paulus, et al.
Melanoma Research|March 14, 2008
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cellsMichael Schwenkert, Katrin Birkholz, Michael Schwemmlein, et al.
The Canadian Journal of Urology|June 19, 2012
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastasesUlf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, et al.
The World Allergy Organization Journal|April 3, 2019
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen seasonRalph Mösges, Nils Y Breitrück, Silke Allekotte, et al.
Pageof 2